| Literature DB >> 35887610 |
Aleksandra Suwalska1, Lukasz Zientek2, Joanna Polanska1, Michal Marczyk1,3.
Abstract
Tumor-infiltrating lymphocytes (TILs), identified on HE-stained histopathological images in the cancer area, are indicators of the adaptive immune response against cancers and play a major role in personalized cancer immunotherapy. Recent works indicate that the spatial organization of TILs may be prognostic of disease-specific survival and recurrence. However, there are a limited number of methods that were proposed and tested in analyses of the spatial structure of TILs. In this work, we evaluated 14 different spatial measures, including the one developed for other omics data, on 10,532 TIL maps from 23 cancer types in terms of reproducibility, uniqueness, and impact on patient survival. For each spatial measure, 16 different scenarios for the definition of prognostic factor were tested. We found no difference in survival prediction when TIL maps were stored as binary images or continuous TIL probability scores. When spatial measures were discretized into a low and high category, a higher correlation with survival was observed. Three measures with the highest cancer prognosis capability were spatial autocorrelation, GLCM M1, and closeness centrality. Most of the tested measures could be further tuned to increase prediction performance.Entities:
Keywords: TILs; cancer prognosis; histopathological images; spatial measures; survival
Year: 2022 PMID: 35887610 PMCID: PMC9317291 DOI: 10.3390/jpm12071113
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426
Data description. TIL maps represent original images with TIL information, while regions of interest (ROIs) are tissue regions separated during the data-preprocessing step. One or more TIL maps were available per patient.
| Cancer | Acronym | Patients | TIL Maps | ROIs |
|---|---|---|---|---|
| Adrenocortical carcinoma | acc | 92 | 323 | 391 |
| Bladder urothelial carcinoma | blca | 179 | 179 | 223 |
| Breast invasive carcinoma | brca | 1067 | 1068 | 1312 |
| Cervical squamous cell carcinoma and endocervical adenocarcinoma | cesc | 268 | 268 | 526 |
| Colon adenocarcinoma | coad | 452 | 453 | 630 |
| Esophageal carcinoma | esca | 156 | 156 | 223 |
| Head and neck squamous cell carcinoma | hnsc | 450 | 450 | 698 |
| Kidney renal clear cell carcinoma | kirc | 513 | 514 | 626 |
| Liver hepatocellular carcinoma | lihc | 365 | 365 | 490 |
| Lung adenocarcinoma | luad | 479 | 480 | 662 |
| Lung squamous cell carcinoma | lusc | 484 | 484 | 655 |
| Mesothelioma | meso | 87 | 175 | 347 |
| Ovarian serous cystadenocarcinoma | ov | 106 | 106 | 180 |
| Pancreatic adenocarcinoma | paad | 183 | 189 | 253 |
| Prostate adenocarcinoma | prad | 403 | 403 | 548 |
| Rectum adenocarcinoma | read | 165 | 165 | 251 |
| Sarcoma | sarc | 255 | 255 | 316 |
| Skin cutaneous melanoma | skcm | 434 | 448 | 611 |
| Stomach adenocarcinoma | stad | 434 | 434 | 454 |
| Testicular germ cell tumors | tgct | 149 | 154 | 190 |
| Thymoma | thym | 121 | 121 | 152 |
| Uterine corpus endometrial carcinoma | ucec | 504 | 506 | 699 |
| Uveal melanoma | uvm | 80 | 80 | 95 |
Figure 1Example of TIL maps representing images consisting of two different tissue fragments present on the same slide (A) or two adjacent slices of the same tissue fragment (B). Top rows show original TIL maps, while bottom rows are regions of interest (ROIs) that were provided after data preprocessing.
Figure 2Comparison of spatial measures between two formats of TIL maps. (A) Spearman correlation of each spatial-measure value within each cancer type between binary and probability TIL maps. Black rectangles represent cases where NA values were present for all images within cancer type for at least one TIL map scale. (B) Scatter plots visualizing results for individual TIL maps within each spatial measure.
Figure 3Variation of spatial measures across ROIs and patients estimated by robust coefficient of variation (CV). Boxplots shows reproducibility of measures calculated on different ROIs from the same patient for binary TIL maps (A) and probabilities (B). Heatmaps represent CV across patients for binary TIL maps (C) and probabilities (D). Black rectangles show situations where spatial measures could not be calculated or median across patients within the same cancer type was equal to 0.
Figure 4Result of survival analysis. Top: Distribution of Harrell’s concordance index from survival analysis across different cancer types for overall survival (A) and progression-free interval (B). Bottom: Heatmaps presenting hazard ratios per cancer type and spatial-measure scale (continuous or discretized) for overall survival (C) and progression-free interval (D). Single star indicates p-value lower than 0.05, and two stars lower than 0.01.
Figure 5Detailed survival analysis results for skcm cancer type. Forest plots compare hazard ratios with confidence intervals between spatial measures for each Cox model type and measure scale separately for binary TIL maps (A) and probabilities (B). Kaplan–Meier curves of selected discretized spatial measures for adjusted model: spatial chaos (C) and Ripley’s L (D).